Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Verena Nilius-Eliliwi"'
Autor:
Enver Aydilek, Susanne Klein-Scory, Julia Thomson, Verena Nilius-Eliliwi, Deepak Vangala, Roland Schroers, Gerald Wulf, Thomas Mika
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e949 (2023)
Externí odkaz:
https://doaj.org/article/431080bd890e41c6aeded3c7b4d65385
Publikováno v:
Neurological Research and Practice, Vol 5, Iss 1, Pp 1-11 (2023)
Abstract Background Treatment of relapsed or refractory primary CNS lymphoma (r/r PCNSL) is difficult, particularly in patients not eligible for high dose chemotherapy with autologous stem cell transplantation (HDC-ASCT). No standard treatment has be
Externí odkaz:
https://doaj.org/article/4ee914dac12f43c096e196bd5866ab58
Autor:
Hannes Treiber, Verena Nilius-Eliliwi, Nicole Seifert, Deepak Vangala, Meng Wang, Sabine Seidel, Thomas Mika, Dominik Marschner, Vanja Zeremski, Rebecca Wurm-Kuczera, Leandra Caillé, Claudia I. Chapuy, Lorenz Trümper, Thomas Fischer, Michael Altenbuchinger, Gerald G. Wulf, Gerald Illerhaus, Sascha Dietrich, Roland Schroers, Björn Chapuy
Publikováno v:
HemaSphere, Vol 7, Iss 8, p e926 (2023)
Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively trea
Externí odkaz:
https://doaj.org/article/e74a68f6168d4ee3a17dc8e62bf03165
Autor:
Thomas Mika, Julia Thomson, Verena Nilius-Eliliwi, Deepak Vangala, Alexander Baraniskin, Gerald Wulf, Susanne Klein-Scory, Roland Schroers
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 539-550 (2021)
Chimeric antigen receptor (CAR)-T cells are increasingly used for the treatment of hematologic malignancies. Treatment success relies highly upon sufficient expansion of CAR-T effector cells. Accordingly, longitudinal quantification of CAR-T cells du
Externí odkaz:
https://doaj.org/article/05e6edc5484e40d886ac9ef87c30d4ee
Autor:
Verena Nilius-Eliliwi, Marco Tembrink, Wanda Maria Gerding, Krzystof P. Lubieniecki, Joanna M. Lubieniecka, Stefanie Kankel, Thomas Liehr, Thomas Mika, Fotios Dimopoulos, Konstanze Döhner, Roland Schroers, Hoa Huu Phuc Nguyen, Deepak Ben Vangala
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In acute myeloid leukemia (AML), treatment decisions are currently made according to the risk classification of the European LeukemiaNet (ELN), which is based on genetic alterations. Recently, optical genome mapping (OGM) as a novel method proved to
Externí odkaz:
https://doaj.org/article/239df1092c224ff3a861dde340cd6900
Autor:
Marco Tembrink, Wanda Maria Gerding, Stefan Wieczorek, Thomas Mika, Roland Schroers, Huu Phuc Nguyen, Deepak Ben Vangala, Verena Nilius-Eliliwi
Publikováno v:
Cancers, Vol 15, Iss 11, p 2942 (2023)
Optical genome mapping (OGM) recently has demonstrated the potential to improve genetic diagnostics in acute myeloid leukemia (AML). In this study, OGM was utilized as a tool for the detection of genome-wide structural variants and disease monitoring
Externí odkaz:
https://doaj.org/article/aade43abf9434fa8b88476e41ef45322
Autor:
Lisa-Marie Vieler, Verena Nilius-Eliliwi, Roland Schroers, Deepak Ben Vangala, Huu Phuc Nguyen, Wanda Maria Gerding
Publikováno v:
Genes, Vol 14, Iss 3, p 686 (2023)
(1) Background: In acute lymphoblastic leukemia (ALL) the genetic characterization remains challenging. Due to the genetic heterogeneity of mutations in adult patients, only a small proportion of aberrations can be analyzed with standard routine diag
Externí odkaz:
https://doaj.org/article/36665d2ffb06477f93a6a03f81bba594
Publikováno v:
Cancers, Vol 15, Iss 6, p 1684 (2023)
The classification and risk stratification of acute myeloid leukemia (AML) is based on reliable genetic diagnostics. A broad and expanding variety of relevant aberrations are structural variants beyond single-nucleotide variants. Optical Genome Mappi
Externí odkaz:
https://doaj.org/article/8044125cd05145fa8bb2bea74e9670dd
Autor:
Deepak B. Vangala, Verena Nilius-Eliliwi, Thomas Mika, Thilo Gambichler, Rene Stranzenbach, Roland Schroers
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/c24dad81770946bca2ffacd09ecb9a61
Autor:
Verena Nilius-Eliliwi, Thomas Mika, Alexander Baraniskin, Max Wünnenberg, Marina Maslova, Christian Boy, Susanne Klein-Scory, Roland Schroers, Deepak Vangala
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
In patients with compromised immune function, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (CoVID-19) impose particular challenges. Especially in hematological malignancies, including lymphoma, t
Externí odkaz:
https://doaj.org/article/94ccd9398fe04ac880aa263f580c202a